Last year, I published a paper that showed that cancer mortality rates fell by 24% between 2000 and 2016 and further that new cancer drugs accounted for saving 1.3 million lives in the US over that time period. At the end of the paper, we noted that these numbers may be conservative since the use of new innovations–such as immuno-oncology, CAR-T therapy and others–took off after 2016.
It turns out that our premonition was correct, based on the findings from the American Cancer Society’s 2021 Facts & Figures report.
From 1991 to 2018, the cancer death rate has
Read more Source: healthcare-economist.com